Page last updated: 2024-08-25

rosiglitazone and Encephalopathy, Hepatic

rosiglitazone has been researched along with Encephalopathy, Hepatic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ding, S; Wang, X; Wen, F; Xu, Z; Yang, J; Zhuge, Q; Zhuge, W	1

Other Studies

1 other study(ies) available for rosiglitazone and Encephalopathy, Hepatic

Article	Year
Insulin Resistance Disrupts the Interaction Between AKT and the NMDA Receptor and the Inactivation of the CaMKIV/CREB Pathway in Minimal Hepatic Encephalopathy. Toxicological sciences : an official journal of the Society of Toxicology, 2017, 10-01, Volume: 159, Issue:2 Topics: Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 4; Cells, Cultured; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Hepatic Encephalopathy; Hippocampus; Hypoglycemic Agents; Insulin Resistance; Maze Learning; Phosphorylation; Protein Binding; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptor, Insulin; Receptors, N-Methyl-D-Aspartate; Rosiglitazone; Thiazolidinediones	2017

Article

Year

Insulin Resistance Disrupts the Interaction Between AKT and the NMDA Receptor and the Inactivation of the CaMKIV/CREB Pathway in Minimal Hepatic Encephalopathy.

Toxicological sciences : an official journal of the Society of Toxicology, 2017, 10-01, Volume: 159, Issue:2

Topics: Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 4; Cells, Cultured; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Hepatic Encephalopathy; Hippocampus; Hypoglycemic Agents; Insulin Resistance; Maze Learning; Phosphorylation; Protein Binding; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptor, Insulin; Receptors, N-Methyl-D-Aspartate; Rosiglitazone; Thiazolidinediones

2017